Amanote Research

Amanote Research

    RegisterSign In

NF-κB: A New Player in Angiostatic Therapy

Angiogenesis - Netherlands
doi 10.1007/s10456-008-9094-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchClinical BiochemistryPhysiology
Date

February 19, 2008

Authors
Sebastien P. TabruynArjan W. Griffioen
Publisher

Springer Science and Business Media LLC


Related search

miR-34a: A New Player in the Regulation of T Cell Function by Modulation of NF-κB Signaling

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Targeting the Alternative NF-κB Pathway in Pancreatic Cancer: A New Direction for Therapy?

Expert Review of Anticancer Therapy
OncologyPharmacology
2013English

Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys

Journal of NeuroImmune Pharmacology
NeuroscienceAllergyImmunologyPharmacology
2012English

Multifocal Angiostatic Therapy: An Update

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2005English

NF-κB

Science-Business eXchange
2008English

NF-κB in Immunobiology

Cell Research
Cell BiologyMolecular Biology
2011English

New Insights Into NF-κB Regulation and Function

Trends in Immunology
AllergyImmunology
2008English

Ubiquitin in NF-κB Signaling

Chemical Reviews
Chemistry
2009English

Hypoxia Induced NF-κB

Cells
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy